Ana Echarri

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

María Chaparro, Ana Garre, Andrea Núñez Ortiz et al. · Journal of Clinical Medicine · 2021 · 95 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +10

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial

Antonio López–Sanromán, Isabel Vera‐Mendoza, Eugeni Domènech et al. · Journal of Crohn s and Colitis · 2017 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Fecal Calprotectin in Ileal Crohnʼs Disease

Elena Cerrillo, Belén Beltrán, Salvador Pous et al. · Inflammatory Bowel Diseases · 2015 · 64 citations · Full text

Medicine, Clinical Sciences, Pathology +17

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.

William Zabala‐Fernández, Manuel Barreiro‐de Acosta, Ana Echarri et al. · PubMed · 2011 · 48 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +16

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease

Ana Echarri, Virginia Ollero, Manuel Barreiro‐de Acosta et al. · European Journal of Gastroenterology & Hepatology · 2015 · 46 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14